Citation Impact
Citing Papers
Subpolar addition of new cell wall is directed by DivIVA in mycobacteria
2014 StandoutNobel
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Heparin-Protein Interactions
2002 Standout
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users
2001
Initial Experience on Rifampin and Pyrazinamide vs Isoniazid in the Treatment of Latent Tuberculosis Infection Among Patients With Silicosis in Hong Kong
2003
Vaccine hesitancy: Definition, scope and determinants
2015 Standout
Validity of verbal autopsy procedures for determining cause of death in Tanzania
2006
Landscape Analysis of Interactions between Nutrition and Vaccine Responses in Children
2009
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD
2009
Vaccinations in the third world: A consideration of community demand
1995
Tratamiento directamente observado de la infección tuberculosa latente: estudio comparativo de dos pautas con isoniacida
2003
Infant Survival Is Improved by Oral Iodine Supplementation ,
1997
Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries
1995
Meta-analysis of intervention trials on case-management of pneumonia in community settings
1992
Users' Guides to the Medical Literature
1998 Standout
Revaccination with Live Attenuated Vaccines Confer Additional Beneficial Nonspecific Effects on Overall Survival: A Review
2016
The burden of non-communicable diseases in South Africa
2009 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV‐1 by deletion of the env amino‐terminal signal sequence
1990 StandoutNobel
Attitudes to vaccination: A critical review
2014 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Global Burden of Tuberculosis
1999 Standout
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
1998 Standout
Thrice-Weekly Sulfadiazine-Pyrimethamine for Maintenance Therapy of Toxoplasmic Encephalitis in HIV-Infected Patients
2000
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
1996
Treatment of latent infection withMycobacterium tuberculosis: update 2010
2010
Immune Responses During Measles Virus Infection
1995
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study
2002
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
2012 Standout
Human Immunodeficiency Virus Type 1 Neutralizing Antibody Serotyping Using Serum Pools and an Infectivity Reduction Assay
1996
Hepatotoxicity Associated With Isoniazid Preventive Therapy
1999
HIV as the cause of AIDS
1996 StandoutNobel
The Adolescent Brain
2008 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
What works? Interventions for maternal and child undernutrition and survival
2008 Standout
Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions
2004 Standout
Iodine-deficiency disorders
2008 Standout
Evolution of complex disasters
1995 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Human Immunodeficiency Virus Infection and AIDS in a Person with Negative Serology
1997 StandoutNobel
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial
2010
Virus-Induced Immunosuppression: Infections with Measles Virus and Human Immunodeficiency Virus
1989
Selection of Maternal Human Immunodeficiency Virus Type 1 Variants in Human Placenta
1999 StandoutNobel
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
2014 Standout
Verbal Autopsy: Methods in Transition
2010
How many child deaths can we prevent this year?
2003 Standout
Food-Related Illness and Death in the United States
1999 Standout
Silicosis
2012 Standout
Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis
2003
General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1994 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
1991
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Molecular Physiology of P2X Receptors
2002 Standout
Cell-to-Cell Contact Results in a Selective Translocation of Maternal Human Immunodeficiency Virus Type 1 Quasispecies across a Trophoblastic Barrier by both Transcytosis and Infection
2001 StandoutNobel
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
A Comprehensive Panel of Near-Full-Length Clones and Reference Sequences for Non-Subtype B Isolates of Human Immunodeficiency Virus Type 1
1998 StandoutNobel
Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
1998
Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons
1992
Interventions for enhancing medication adherence
2008 Standout
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160
1993 StandoutNobel
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission
1995
Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme.
1995
Research into health, population and social transitions in rural South Africa: Data and methods of the Agincourt Health and Demographic Surveillance System1
2007
Adverse reactions to first-line antituberculosis drugs
2006
Addressing Parents’ Concerns: Do Multiple Vaccines Overwhelm or Weaken the Infant’s Immune System?
2002
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
Optimal ages of vaccination for measles
1988
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Pathogenesis of human immunodeficiency virus infection
1993
Interventions for enhancing medication adherence
2014 Standout
Measles prevention and control in emergency settings.
1989
ATP-Induced Killing of VirulentMycobacterium tuberculosisWithin Human Macrophages Requires Phospholipase D
2000
Neutralization of HIV‐1: a paradox of humoral proportions
1991
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
1995 StandoutNobel
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
1998 StandoutScience
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The Mathematics of Infectious Diseases
2000 Standout
Protection Elicited by a Double Leucine and Pantothenate Auxotroph of Mycobacterium tuberculosis in Guinea Pigs
2004
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160
1992 StandoutNobel
Increasing Latino Adolescents’ Adherence to Treatment for Latent Tuberculosis Infection: A Controlled Trial
2003
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Works of Reginald Boulos being referenced
The utility of verbal autopsies for identifying HIV-1-related deaths in Haitian children
1993
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
1998
Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature.
1995
Bacillus Calmette-Guerin Complications in Children Born to HIV-1-Infected Women With a Review of the Literature
1995
Human immunodeficiency virus neutralizing antibodies in sera from North Americans and Africans.
1990
Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission.
1992
Childhood Survival in Haiti: Protective Effect of Measles Vaccination
1990
HIV-1 in Haitian women 1982-1988. The Cite Soleil/JHU AIDS Project Team.
1990
Response to Measles Vaccine in Haitian Infants 6 to 12 Months Old
1985